Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug;87(8):753-9.
doi: 10.1016/j.mayocp.2012.02.025. Epub 2012 Jul 13.

Incidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olmsted County, Minnesota

Sanjeev K Swami  1 , Juliette T Liesinger, Nilay Shah, Larry M Baddour, Ritu Banerjee
Affiliations

Incidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olmsted County, Minnesota

Sanjeev K Swami et al. Mayo Clin Proc. 2012 Aug.

Abstract

Objective: To better understand the epidemiology of drug-resistant Escherichia coli across health care and community settings.

Patients and methods: We conducted a population-based cohort study of the incidence of antibiotic-resistant E coli bacteriuria among different patient groups. All urine cultures with monomicrobial growth of E coli obtained from Olmsted County, Minnesota, residents from January 1, 2005, through December 31, 2009, were identified. The initial isolate per patient per year was included. Analyses were stratified by patient age and location of infection onset (ie, nosocomial, health care associated, and community associated).

Results: We evaluated 5619 E coli isolates and the associated patients. During the study period, the incidence of drug-resistant bacteriuria did not change among children but increased significantly among adults of all ages, most markedly among elderly patients older than 80 years. In elderly patients, the incidence of bacteriuria with isolates resistant to fluoroquinolones increased from 464 to 1116 per 100,000 person-years (P<.001), and the incidence of bacteriuria with isolates resistant to fluoroquinolones plus trimethoprim-sulfamethoxazole increased from 274 to 512 per 100,000 person-years (P<.05). When analyzed by location of infection onset, incidence of bacteriuria with isolates resistant to trimethoprim-sulfamethoxazole, fluoroquinolones, trimethoprim-sulfamethoxazole plus fluoroquinolones, extended-spectrum cephalosporins, and more than 3 drug classes increased significantly among community-associated but not among nosocomial or health care-associated cases.

Conclusion: In this population-based study, the incidence of antibiotic-resistant E coli bacteriuria nearly doubled during the 5-year study period among elderly patients and those with community-associated isolates. These patient groups should be targets of interventions to slow the emergence and spread of antibiotic-resistant E coli.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Incidence of Escherichia coli bacteriuria by age, Olmsted County, Minnesota, 2005-2009. A, Drug-susceptible isolates. B, Fluoroquinolone-resistant isolates. C, Trimethoprim-sulfamethoxazole–resistant isolates. D, Extended-spectrum cephalosporin–resistant isolates. Asterisk indicates P<.05.
FIGURE 2
FIGURE 2
Incidence of Escherichia coli bacteriuria by location of onset, Olmsted County, Minnesota, 2005-2009. A, Drug-susceptible isolates. B, Fluoroquinolone-resistant isolates. C, Trimethoprim-sulfamethoxazole–resistant isolates. D, Extended-spectrum cephalosporin–resistant isolates. CA = community associated; HA = health care associated. Asterisk indicates P<.05.
See this image and copyright information in PMC

References

    1. Johnson J.R., Johnston B., Clabots C., Kuskowski M.A., Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis. 2010;51(3):286–294. - PubMed
    1. Johnson J.R., Menard M., Johnston B., Kuskowski M.A., Nichol K., Zhanel G.G. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother. 2009;53(7):2733–2739. - PMC - PubMed
    1. Rogers B.A., Sidjabat H.E., Paterson D.L. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother. 2011;66(1):1–14. - PubMed
    1. Cagnacci S., Gualco L., Debbia E., Schito G.C., Marchese A. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J Clin Microbiol. 2008;46(8):2605–2612. - PMC - PubMed
    1. Nicolas-Chanoine M.-H., Blanco J., Leflon-Guibout V. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother. 2008;61(2):273–281. - PubMed

Publication types

MeSH terms

Substances